| 000 | 01751 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517162448.0 | ||
| 264 | 0 | _c20180713 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/jgh.13852 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKimer, Nina | |
| 245 | 0 | 0 |
_aRifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cJan 2018 |
||
| 300 |
_a307-314 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBacterial Translocation _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aDNA, Bacterial _xblood |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestines _xmicrobiology |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRifamycins _xadministration & dosage |
| 650 | 0 | 4 | _aRifaximin |
| 700 | 1 | _aPedersen, Julie S | |
| 700 | 1 | _aTavenier, Juliette | |
| 700 | 1 | _aChristensen, Jeffrey E | |
| 700 | 1 | _aBusk, Troels M | |
| 700 | 1 | _aHobolth, Lise | |
| 700 | 1 | _aKrag, Aleksander | |
| 700 | 1 | _aAl-Soud, Waleed Abu | |
| 700 | 1 | _aMortensen, Martin S | |
| 700 | 1 | _aSørensen, Søren J | |
| 700 | 1 | _aMøller, Søren | |
| 700 | 1 | _aBendtsen, Flemming | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 33 _gno. 1 _gp. 307-314 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jgh.13852 _zAvailable from publisher's website |
| 999 |
_c27333011 _d27333011 |
||